While uncommon, ongoing headaches may indicate dehydration, medication sensitivity, or an unrelated condition requiring evaluation
Par exemple, Lilly prvoit de publier en 2025 des donnes de phase 3 sur lorfoglipron, un agoniste GLP-1 oral, et le retatrutide, un agoniste triple des rcepteurs GLP/GIP/glucagon 3 Xie, Y., Choi, T., & Al-Aly, Z
A clinician should also match the setting to the complexity of the case
Rationale and design of a multicenter chronic kidney disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
HBS Expands Miami Office & Welcomes Five Attorneys Hall Booth Smith bolsters its Miami team by welcoming five talented and enthusiastic attorneys
Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice